Clinical Trials · NCT02388464
A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 36
- Start date
- Jul 2014
- Locations
- 1 site, Bulgaria
- Primary endpoint
- Incidence of Adverse Events